Tuberculosis remains one of the most consequential infectious disease failures of the modern era — a pathogen ancient enough to have infected Egyptian mummies yet still killing more people annually than HIV. The most comprehensive longitudinal mapping of TB's global footprint to date reveals how far the world stands from its own declared targets, and why funding retreats now carry outsized consequences for decades ahead.
Drawing on the Global Burden of Disease Study 2023 — spanning 204 countries and territories from 1990 through 2023 — this systematic analysis quantified TB mortality, incidence, prevalence, and disability-adjusted life-years (DALYs) using ensemble cause-of-death modeling and the DisMod-MR 2.1 platform. Crucially, estimates were stratified by HIV co-infection status and drug-resistance profile, including multidrug-resistant TB (MDR-TB). A comparative risk assessment framework separately attributed burden fractions to modifiable risk factors: alcohol use, cigarette smoking, and elevated fasting plasma glucose. The WHO End TB Strategy's dual benchmarks — a 95% reduction in TB deaths and 90% reduction in incidence between 2015 and 2035 — served as the evaluative reference point, and current trajectories appear substantially off pace for both.
This analysis carries important caveats inherent to any global modeling exercise: cause-of-death data quality varies enormously by region, verbal autopsy and minimal tissue sampling introduce uncertainty, and HIV-TB co-infection ascertainment remains incomplete in high-burden settings. That said, the GBD framework represents the gold standard for comparative burden estimation at this scale. What makes this report particularly significant is its timing — published as international TB funding faces structural contraction — providing an essential epidemiological baseline before disruptions propagate through surveillance and treatment pipelines. For adults in low-burden, high-income settings, the practical implication is indirect but real: MDR-TB reservoirs in under-resourced nations are a global resistance threat that no country's healthcare system is fully insulated from. This study is confirmatory of known trend failures but paradigm-relevant given its scope, recency, and policy urgency.